Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2015-08-04
Product name
Olanzapine for Injection
1.2.1 Relevant identified uses
Injectable Antipsychotic
Icons in SDS
Company Information
company name
PharmaForce, Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H232, H302, H317, H318
Hazard statements
Code
Statements
H232
May ignite spontaneously if exposed to air
Section 2
Classification (GHS-US)
Comb. Dust H232 Acute Tox. 4 (Oral) H302 Eye Dam. 1 H318 Skin Sens. 1 H317
Hazard statements
see section 16 : H232 - May form combustible dust concentrations in air. H302 - Harmful if swallowed. H317 - May cause an allergic skin reaction. H318 - Causes serious eye damage.
2.2 Label elements
GHS-US Labeling
Hazard pictograms
GHS05 GHS07
Signal word
Danger
Precautionary statements
P261 - Avoid breathing vapors, mist, or spray. P264 - Wash hands, forearms, and other exposed areas thoroughly after handling. P270 - Do not eat, drink or smoke when using this product. P272 - Contaminated work clothing must not be allowed out of the workplace. P280 - Wear protective gloves, protective clothing, and eye protection. P301+P312 - If swallowed: Call a poison center or doctor if you feel unwell. P302+P352 - If on skin: Wash with plenty of water. P305+P351+P338 - If in eyes: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 - Immediately call a poison center or doctor. P321 - Specific treatment (see section 4 on this SDS). P330 - Rinse mouth. P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. P362+P364 - Take off contaminated clothing and wash it before reuse. P501 - Dispose of contents/container in accordance with local, regional, national, and international regulations.
Other hazards
Exposure may aggravate those with pre-existing eye, skin, or respiratory conditions. Therapeutic use has resulted in the following adverse effects: sleepiness, weight gain, increases in serum prolactin, dizziness, weakness, restlessness, increase appetite, swelling of hands and feet, decreased blood pressure when standing, dry mouth and constipation. Overdose of the drug has resulted in changes in heart rate and rhythm, slurred speech, reduced level of consciousness ranging from sedation to coma. 2.4.
Ingredient(s) with unknown acute toxicity
No data available
